Stockreport

Longeveron Announces Closing of Private Placement of up to $30 Million

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF $15 million upfront with a milestone-driven potential additional $15 million related to the Company’s anticipated pivotal clinical trial in Hypoplastic Left Heart Syndro [Read more]